Login/Sign Up
₹47085*
₹40022.25*
MRP ₹47085
15% CB
₹7062.75 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Rexafor 24 mg Injection 1.2 ml is used in the treatment of Non-Hodgkin’s Disease (a blood cancer that affects your lymph system) and multiple myeloma (a type of cancer that affects the plasma cells of the bone marrow). Rexafor 24 mg Injection 1.2 ml contains Plerixafor, which belongs to the hemopoietic stem cell mobilizer class or drugs. It works by releasing stem cells from the bone marrow, making them available to collect from your bloodstream.
Provide Delivery Location
Available Offers
Whats That
About Rexafor 24 mg Injection 1.2 ml
Rexafor 24 mg Injection 1.2 ml belongs to the class of hemopoietic stem cell mobilizer. It is used in the treatment of Non-Hodgkin’s Disease (a blood cancer that affects your lymph system) and multiple myeloma (a type of cancer that affects the plasma cells of the bone marrow) in combination with granulocyte-colony stimulating factor (G-CSF).
Rexafor 24 mg Injection 1.2 ml contains Plerixafor, which belongs to the hemopoietic stem cell mobilizer class or drugs. It works by binding to the chemokine receptor CXCR4 and inhibits the binding of its cognate ligand CXCL12.
Rexafor 24 mg Injection 1.2 ml may cause certain side effects, such as nausea, vomiting, headache, dizziness, diarrhoea, flatulence, fatigue, and pain at the site of injection. These side effects do not require medical attention and gradually resolve over time. A trained healthcare professional will administer it. Do not self-administer.
Avoid taking it and inform your doctor if you are allergic to Rexafor 24 mg Injection 1.2 ml or its components. Before administration, inform your doctor if you have liver/kidney disease, cardiac disorders, blood disorders or respiratory conditions. This medicine is known to cause fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. Breastfeeding should be discontinued during the treatment.
Uses of Rexafor 24 mg Injection 1.2 ml
Directions for Use
Medicinal Benefits
Rexafor 24 mg Injection 1.2 ml contains Plerixafor, which belongs to the hemopoietic stem cell mobilizer class or drugs. It works by binding to the chemokine receptor CXCR4 and inhibiting its cognate ligand CXCL12 binding. This mobilizes hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in cancer patients.
How Rexafor 24 mg Injection 1.2 ml Works
Storage
What if I have taken an overdose of Rexafor 24 mg Injection 1.2 ml
Drug Warnings
Rexafor 24 mg Injection 1.2 ml should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before administration, inform your doctor if you have liver/kidney disease, cardiac disorders, blood disorders, anaemia, or respiratory conditions. Rexafor 24 mg Injection 1.2 ml may cause the potential for tumor cell mobilization in leukemia patients, haematological effects, and splenic rupture in some patients. Hence, careful monitoring should be done during the entire treatment. This medicine is known to cause fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. Breastfeeding should be discontinued in nursing mothers during the treatment. Rexafor 24 mg Injection 1.2 ml should be avoided in children as safety is not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
Alcohol
Unsafe
It is unknown whether Rexafor 24 mg Injection 1.2 ml interacts with alcohol or not. Please consult your doctor.
Pregnancy
Unsafe
Rexafor 24 mg Injection 1.2 ml is not recommended for use in pregnancy as it may harm your fetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Rexafor 24 mg Injection 1.2 ml. Effective birth control is necessary during treatment and for one week after your last dose.
Breast Feeding
Unsafe
Rexafor 24 mg Injection 1.2 ml is not recommended if you are breastfeeding. You should not breastfeed while taking this medication and for one week after your last dose.
Driving
Caution
Rexafor 24 mg Injection 1.2 ml is generally administered to hospitalized patients. Driving is not advised after taking this medicine.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Rexafor 24 mg Injection 1.2 ml. A dose adjustment may be made, or a suitable alternative may be advised based on your condition.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Rexafor 24 mg Injection 1.2 ml. A dose adjustment may be made, or a suitable alternative may be advised based on your condition.
Children
Unsafe
Rexafor 24 mg Injection 1.2 ml is not recommended for use in children as the safety and efficacy are not established.
Have a query?
Rexafor 24 mg Injection 1.2 ml is used to treat Multiple Myeloma, Non-Hodgkin’s Disease.
Rexafor 24 mg Injection 1.2 ml contains Plerixafor, which works by binding to the chemokine receptor CXCR4 and inhibits the binding of its cognate ligand CXCL12.
Rexafor 24 mg Injection 1.2 ml may cause tumor cell mobilization and haematological effects such as increased lymphocytes, decreased platelet count, and splenic rupture in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information